Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Brimonidine Tartrate Eye Drops

Approval Number

国药准字H20253121

Company广东众生药业股份有限公司

Registration Date

January 8, 2025

Drug Information

Generic Name

酒石酸溴莫尼定滴眼液

Dosage Form

眼用制剂

Strength

0.2%（5ml∶10mg）

Drug Type

化学药品

Registration Date

January 8, 2025

Company Information

Applicant Company

Company Name广东众生药业股份有限公司

Company Address

广东省东莞市石龙镇西湖工业区信息产业园

Manufacturing Company

Company Name广东众生药业股份有限公司

Company Address

广东省东莞市石龙镇西湖工业区信息产业园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy